The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

Approximately 160 tests are set to be conducted annually by the NHS to screen for 'high-risk' genetic variants.

The federal government vows to ban life insurers from using genetic testing results to refuse cover or hike premiums, but ...

Figuring out what causes cancer can be a frightening mystery, but sometimes it's in your genes. So who should get genetic ...

Hundreds of potential kidney donors of Black African and Black Caribbean heritage in the UK can now get a simple blood test to help reduce the risk of kidney failure.

AlleyWatch sat down with Nucleus CEO and Founder Kian Sadeghi to learn more about the business, its future plans, and recent ...

The NHS has launched a new genetic blood test to improve the safety of kidney donations from people of Black African and ...

Investors like Alexis Ohanian’s Seven Seven Six, Balaji Srinivasan and SpaceX alum Achal Upadhyaya have all rallied behind Sadeghi’s vision for widely available genetic testing. “DNA is ...

Significant racial disparities persisted in genetic testing for inborn errors of immunity despite the removal of financial barriers, according to a study published in The Journal of Allergy and ...

The test is part of national genetic testing available on the NHS and will help identify if potential donors carry genes that mean they have a high risk of kidney disease after donation.